Lauralyn McIntyre
Overview
    Explore the profile of Lauralyn McIntyre including associated specialties, affiliations and a list of published articles.
          
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              142
            
            
              Citations
              6386
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          Published In
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Takaoka A, Johnstone J, Lauzier F, Heels-Ansdell D, Davis M, Zytaruk N, et al.
  
  
    Trials
    . 2024 Dec;
          25(1):851.
    
    PMID: 39731129
  
  
          Background: Understanding site-related factors that influence enrolment within multicenter randomized controlled trials (RCT) may help reduce trial delays and cost over-runs and prevent early trial discontinuation. In this analysis of...
      
2.
        
    
    English S, Delaney A, Fergusson D, Chasse M, Turgeon A, Lauzier F, et al.
  
  
    N Engl J Med
    . 2024 Dec;
          392(11):1079-1088.
    
    PMID: 39655786
  
  
          Background: The effect of a liberal red-cell transfusion strategy as compared with a restrictive strategy in patients during the critical care period after an aneurysmal subarachnoid hemorrhage is unclear. Methods:...
      
3.
        
    
    Daneman N, Rishu A, Pinto R, Rogers B, Rogers B, Shehabi Y, et al.
  
  
    N Engl J Med
    . 2024 Nov;
          392(11):1065-1078.
    
    PMID: 39565030
  
  
          Background: Bloodstream infections are associated with substantial morbidity and mortality. Early, appropriate antibiotic therapy is important, but the duration of treatment is uncertain. Methods: In a multicenter, noninferiority trial, we...
      
4.
        
    
    Terrett L, Reszel J, Ameri S, Turgeon A, McIntyre L, English S
  
  
    Neurocrit Care
    . 2024 Oct;
    
    PMID: 39402427
  
  
          In aneurysmal subarachnoid hemorrhage, rebleeding prior to securing the culprit aneurysm leads to significant morbidity and mortality. Elevated blood pressure has been identified as a possible risk factor. In this...
      
5.
        
    
    OHearn K, Menon K, Albrecht L, Amrein K, Britz-McKibbin P, Cayouette F, et al.
  
  
    Trials
    . 2024 Sep;
          25(1):619.
    
    PMID: 39300483
  
  
          Background: The rate of vitamin D deficiency (VDD) in critically ill children worldwide has been estimated at 50%. These children are at risk of multiple organ dysfunction, chronic morbidity, and...
      
6.
        
    
    Andersen C, Presseau J, Shea B, Marti M, McCoy M, Fernie G, et al.
  
  
    Transl Stroke Res
    . 2024 Jul;
          16(1):49-78.
    
    PMID: 38997598
  
  
          Aneurysmal subarachnoid haemorrhage (aSAH) is a devastating condition with high mortality and morbidity. The outcome measures used in aSAH clinical research vary making it challenging to compare and combine different...
      
7.
        
    
    Cook D, Taneja S, Krewulak K, Zytaruk N, Menon K, Fowler R, et al.
  
  
    JAMA Netw Open
    . 2024 Jul;
          7(7):e2420458.
    
    PMID: 38995645
  
  
          Importance: The COVID-19 pandemic created unprecedented challenges for clinical trials worldwide, threatening premature closure and trial integrity. Every phase of research operations was affected, often requiring modifications to protocol design...
      
8.
        
    
    Terrett L, McIntyre L, OKelly C, Ramsay T, Turgeon A, English S
  
  
    Neurocrit Care
    . 2024 Jun;
          41(3):893-902.
    
    PMID: 38862709
  
  
          Background: In aneurysmal subarachnoid hemorrhage (aSAH), rebleeding of the culprit aneurysm is associated with significant morbidity and mortality. Blood pressure reduction to specific target levels, with the goal of preventing...
      
9.
        
    
    Hum C, Tahir U, Mei S, Champagne J, Fergusson D, Lalu M, et al.
  
  
    Stem Cells Transl Med
    . 2024 Feb;
          13(4):346-361.
    
    PMID: 38381583
  
  
          Background: In preclinical studies, mesenchymal stromal cells (MSCs), including umbilical cord-derived MSCs (UC-MSCs), demonstrate the ability to modulate numerous pathophysiological processes related to sepsis; however, a systematic synthesis of the...
      
10.
        
    
    Terrett L, McIntyre L, Turgeon A, English S
  
  
    Neurocrit Care
    . 2023 Aug;
          39(1):91-103.
    
    PMID: 37634181
  
  
          Anemia is very common in aneurysmal subarachnoid hemorrhage (aSAH), with approximately half of the aSAH patient population developing moderate anemia during their hospital stay. The available evidence (both physiologic and...